Brain tumor diagnosis gets a High-Tech upgrade: PET/MRI spots key mutations
NCT ID NCT07405372
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new type of PET/MRI scan that looks for a specific gene change (IDH mutation) in brain tumors called gliomas. Knowing this mutation helps doctors choose the right treatment and predict outcomes. The trial will enroll 10 adults with suspected or known gliomas to see how well the scan works compared to standard methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Nuclear Medicine, Daping Hospital of Army Medical University
RECRUITINGChongqing, Chongqing Municipality, 400010, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a sharper beam of radiation shield the mind during brain tumor treatment?
- Can a tiny implant trap brain tumor cells and make radiation work better?
- Can a targeted pill slow brain tumor growth after surgery?
- Brain surgery gets a GPS: network maps may help remove tumors while preserving function